Dr. Alice Levine has been a faculty member of the Mount Sinai School of Medicine since 1986 when she completed her Fellowship in Endocrinology and Metabolism. She divides her time between clinical, teaching and research activities. Her clinical interests are diseases of the adrenal, pituitary and reproductive glands with an emphasis on hormone-dependent neoplasias. She publishes extensively in these fields. She is the Course Director for the Second Year Medical School Endocrine Pathophysiology Course and is often cited as one of the outstanding Faculty Teachers by Medical Students, Residents and Fellows. In her role as the Program Director of the Endocrine Fellowship, she mentors students, trainees and faculty in clinical and basic science research.
Language
English
Position
PROFESSOR | Medicine, Endocrinology, Diabetes and Bone Disease, ASSOCIATE PROFESSOR | Oncological Sciences
Hospital Affiliations
Mount Sinai Beth Israel
Mount Sinai Morningside
The Mount Sinai Hospital
New York Eye and Ear Infirmary of Mount Sinai
Mount Sinai West
About Me
Dr. Alice Levine has been a faculty member of the Mount Sinai School of Medicine since 1986 when she completed her Fellowship in Endocrinology and Metabolism. She divides her time between clinical, teaching and research activities. Her clinical interests are diseases of the adrenal, pituitary and reproductive glands with an emphasis on hormone-dependent neoplasias. She publishes extensively in these fields. She is the Course Director for the Second Year Medical School Endocrine Pathophysiology Course and is often cited as one of the outstanding Faculty Teachers by Medical Students, Residents and Fellows. In her role as the Program Director of the Endocrine Fellowship, she mentors students, trainees and faculty in clinical and basic science research.
Language
English
Position
PROFESSOR | Medicine, Endocrinology, Diabetes and Bone Disease, ASSOCIATE PROFESSOR | Oncological Sciences
Hospital Affiliations
Mount Sinai Beth Israel
Mount Sinai Morningside
The Mount Sinai Hospital
New York Eye and Ear Infirmary of Mount Sinai
Mount Sinai West
About Me
Dr. Alice Levine has been a faculty member of the Mount Sinai School of Medicine since 1986 when she completed her Fellowship in Endocrinology and Metabolism. She divides her time between clinical, teaching and research activities. Her clinical interests are diseases of the adrenal, pituitary and reproductive glands with an emphasis on hormone-dependent neoplasias. She publishes extensively in these fields. She is the Course Director for the Second Year Medical School Endocrine Pathophysiology Course and is often cited as one of the outstanding Faculty Teachers by Medical Students, Residents and Fellows. In her role as the Program Director of the Endocrine Fellowship, she mentors students, trainees and faculty in clinical and basic science research.
Language
English
Position
PROFESSOR | Medicine, Endocrinology, Diabetes and Bone Disease, ASSOCIATE PROFESSOR | Oncological Sciences
MD, Columbia University College of Physicians & Surgeons
Internship, Internal Medicine
Fletcher Allen Health Care-MCHV Campus
Residency, Internal Medicine
Fletcher Allen Health Care-MCHV Campus
Fellowship, Endocrinology, Diabetes and Metabolism
Mount Sinai Hospital
Certifications
Diabetes & Metabolism
American Board of Internal Medicine
Research
Interactive roles of androgens and growth factors in human
prostate development and neoplasia
Dr. Levine’s Research
Laboratory focuses on understanding
how hormones and growth factors coordinately regulate prostate growth in order
to develop new treatment strategies for men with prostatic disorders.
Co-directed by Dr. Alexander Kirschenbaum, Clinical Associate Professor of
Urology, her group was the first to publish on the successful management of
benign prostatic hyperplasia with hormonal therapy. They also reported
that androgens increase stromal cell growth in the prostate and also regulate
the powerful angiogenic factor, vascular endothelial cell growth factor
(VEGF). Dr. Levine’s group were also among the first to determine the
cell-specific expression of cyclooxygenase-2 (COX-2) in the human prostate and
to report that selective COX-2 inhibitors kill prostate cancer cells in vitro
and in vivo. They established the role of COX-2 in hypoxia mediated
upregulation of survival and angiogenic proteins in human prostate cancer
cells. Dr. Levine’s group recently isolated and characterized a protein
derived from dietary bitter melon seeds that selectively kills pre-neoplastic
and neoplastic prostate cancer cells. Her group has also published
extensively on the mechanisms underlying prostate cancer bone metastases and
developed a bone-targeting compound aimed at preventing and treating prostate
cancer bone metastases.
Accepted insurance may vary by the doctor’s office location. Please contact the office directly to obtain the most up-to-date insurance information.
Department of Medicine-Endocrinology5 East 98th Street, 3rd Floor, New York, NY, 10029
1199 SEIU
AETNA - Commercial
AETNA - Medicare
Affinity Medicaid-Medicare-Essential Exchange
AgeWell New York
CIGNA Healthcare
Centivo
Elderplan
EmblemHealth - HIP
EmblemHealth - HIP-Medicaid
EmblemHealth - HIP-Medicare
Empire Blue Cross Blue Shield - Top Tier
Fidelis Health Care
HealthFirst Medicare
Hotel Trades
Magnacare-Health Care
Medicare - NJ
Medicare - NY
Metroplus
Multiplan PHCS
NJ Medicaid
NY Medicaid
Oxford - Freedom & Liberty
Partners Health Plan
Senior Whole Health
United Health Care - Community Care Medicaid
United Health Care - Empire Plan
United Health Care - Oxford Care
United Health Care - Top Tier
VNSNY Choice Medicare
WellCare Health Plan
Neurosurgery5 E 98th Street, 7th Floor, New York, NY, 10029
1199 SEIU
AETNA - Commercial
AETNA - Medicare
Affinity Medicaid-Medicare-Essential Exchange
AgeWell New York
CIGNA Healthcare
Centivo
Elderplan
EmblemHealth - HIP
EmblemHealth - HIP-Medicaid
EmblemHealth - HIP-Medicare
Empire Blue Cross Blue Shield - Top Tier
Fidelis Health Care
HealthFirst Medicare
Hotel Trades
Magnacare-Health Care
Medicare - NJ
Medicare - NY
Metroplus
Multiplan PHCS
NJ Medicaid
NY Medicaid
Oxford - Freedom & Liberty
Partners Health Plan
Senior Whole Health
United Health Care - Community Care Medicaid
United Health Care - Empire Plan
United Health Care - Oxford Care
United Health Care - Top Tier
VNSNY Choice Medicare
WellCare Health Plan
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.
The Patient Experience Star Rating reflects our patients’ perception of how well their Mount Sinai provider communicated with them during an office visit. The Star Rating is based on patient responses to three questions on a patient experience survey, a standardized questionnaire sent to verified patients and distributed by a third party vendor, Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score.
Care Provider’s Explanation
5 out of 5
Care Provider’s Concern
5 out of 5
Likelihood to Recommend Care Provider
4.9 out of 5
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Levine during 2022 and/or 2023. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Consulting:
HRA Pharma
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.